National Institute of General Medical Sciences; Notice of Closed Meetings

Download PDF
Federal RegisterApr 3, 2000
65 Fed. Reg. 17517 (Apr. 3, 2000)

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute of General Medical Sciences Special Emphasis Panel, Molecular Pharmacology.

Date: March 29-31, 2000.

Time: 8 pm to 12 pm.

Agenda: To review and evaluate grant applications.

Place: The Inn at Penn Hotel, 3600 Sanson Street, Philadelphia, PA 19104.

Contact Person: Arthur L. Zachary, Phd, Scientific Review Administrator, Office of Scientific Review, NIGMS, Natcher Building, Room 1AS-19, Bethesda, MD 20892, (301) 594-2886.

This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle.

Name of Committee: National Institute of General Medical Sciences Special Emphasis Panel, Molecular Pharmacology.

Date: April 3-5, 2000.

Time: 8:00 PM to 12:00 PM.

Agenda: To review and evaluate grant applications.

Place: Lyden Gardens Hotel, 215 E. 64th Street, New York, NY 10021.

Contact Person: Arthur L. Zachary, Phd, Scientific Review Administrator, Office of Scientific Review, NIGMS, Natcher Building, Room 1AS-19, Bethesda, MD 20892, (301) 594-2886.

This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.375, Minority Biomedical Research Support; 93.821, Cell Biology and Biophysics Research; 93.859, Pharmacology, Physiology, and Biological Chemistry Research; 93.862, Genetics and Developmental Biology Research; 93.88, Minority Access to Research Careers; 93.96, Special Minority Initiatives, National Institutes of Health, HHS)

Dated: March 22, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory Committee Policy.

[FR Doc. 00-8099 Filed 3-31-00; 8:45 am]

BILLING CODE 4140-01-M